Original Article

Subject Categories: Cell Biology

Journal of Investigative Dermatology (2007) 127, 762–774. doi:10.1038/sj.jid.5700670; published online 28 December 2006

Increased ICAM-1 Expression Causes Endothelial Cell Leakiness, Cytoskeletal Reorganization and Junctional Alterations

Paul R Clark1,2, Thomas D Manes2,3, Jordan S Pober1,2,3,4 and Martin S Kluger1,2

  1. 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA
  2. 2Interdepartmental Program in Vascular Biology and Transplantation, Yale University School of Medicine, New Haven, Connecticut, USA
  3. 3Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
  4. 4Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA

Correspondence: Dr Martin S. Kluger, 295 Congress Avenue – Room 454, New Haven, Connecticut 06510, USA. E-mail: martin.kluger@yale.edu

Received 27 February 2006; Revised 6 September 2006; Accepted 2 October 2006; Published online 28 December 2006.

Top

Abstract

Tumor necrosis factor (TNF)-induced ICAM-1 in endothelial cells (EC) promotes leukocyte adhesion. Here we report that ICAM-1 also effects EC barrier function. Control- or E-selectin-transduced human dermal microvascular EC (HDMEC) form a barrier to flux of proteins and to passage of current (measured as transendothelial electrical resistance or TEER). HDMEC transduced with ICAM-1 at levels comparable to that induced by TNF show reduced TEER, but do so without overtly changing their cell junctions, cell shape, or cytoskeleton organization. Higher levels of ICAM-1 further reduce TEER, increase F/G-actin ratios, rearrange the actin cytoskeleton to cause cell elongation, and alter junctional zona occludens 1 and vascular endothelial-cadherin staining. Transducing with ICAM-1 lacking an intracellular region also reduces TEER. TNF-induced changes in TEER and shape follow a similar time course as ICAM-1 induction; however, the fall in TEER occurs at lower TNF concentrations. Inhibiting NF-kappaB activation blocks ICAM-1 induction; TEER reduction, and shape change. Specific small-interfering RNA knockdown of ICAM-1 partially inhibits TNF-induced shape change. We conclude that moderately elevated ICAM-1 expression reduces EC barrier function and that expressing higher levels of ICAM-1 affects cell junctions and the cytoskeleton. Induction of ICAM-1 may contribute to but does not fully account for TNF-induced vascular leak and EC shape change.

Abbreviations:

ANOVA, analysis of variance; EC, endothelial cell; HDMEC, human dermal microvascular EC; SRIkappaB, mutagenized S32/36A IkappaBalpha super repressor of NF-kappaB; E-sel, E-selectin; ICAMbasal, ICAMmed, and ICAMhigh, HDMEC transductants expressing ICAM-1 at basal, medium, or high levels, respectively; ICAMDeltaCyto, HDMEC transductants expressing ICAM-1 with the cytoplasmic domain deleted; PBS, phosphate-buffered saline; siRNA, small-interfering RNA; TEER, transendothelial electrical resistance; TNF, tumor necrosis factor; VE-cadhedrin, vascular endothelial cadhedrin; ZO-1, zona occludens 1

Extra navigation

.
ADVERTISEMENT